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1. Introduction
Peroral administration of APIs (Active Pharmaceu-
tical Ingredients) is the most preferred route in drug
therapy especially if the patient compliance aspects
are considered. Peroral delivery includes orally dis-
solving dosage forms, which are in the focus of
numerous industrial research and development
activities owing to their advantages such as:
– instant drug release and rapid onset action (e.g.
against migraine);
– site-specific effect (e.g. sore throat);
– buccal adsorption, avoidance of first pass effect;
– improved oral bioavailability;
– acceptable for patients with swallowing difficul-
ties (e.g. dysphagia, pediatric or geriatric patient,
mental disorders, emesis, motion sickness);
– not requiring mastication or water;
– chance for reformulation of existing drugs (prod-
uct life-cycle management, market competition).
More traditional oral formulations such as syrups
and drops have some considerable disadvantages.
Stability of drugs in liquids is generally much less
than in solid forms due to the higher reactivity of
substances in liquid phase [1]. Furthermore, the
dose precision of liquid formulations is mostly
imperfect. These disadvantages led the European
Medicines Agency (EMEA) to recommend the
development of solid dosage forms instead of oral
liquid dosage forms [2].
The orally disintegrating tablet formulation (ODT)
[3] meets the EMEA recommendation. Administra-
tion of ODTs is easy and there is no need to swal-
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low large particles or water. The required disinte-
gration time of ODTs has to be less than 30 s which
needs much care during the manufacturing. Com-
pression force and hardness of the tablet are critical
parameters of manufacturing of ODTs. If the com-
pression force is too high the disintegration time
increases over the established limit. In contrast, if
the compression force is low the mechanical prop-
erties of the tablet will be weak, leading to fragile
and brittle tablets of weak resistance against
mechanical shocks during manufacturing, storage,
packaging, transportation and intake. Another type
of ODTs produced by freeze-drying is often very
porous, brittle and fragile.
The most recent researches in the field of orally dis-
solving solid dosage forms have been dealing with
oral thin film technology (OTF) which is a rela-
tively new area of interest regarding the oral admin-
istration. The first commercial success of oral thin
films appeared in the United States (Listerine Pock-
etPaks). Nowadays several products, manufactured
by this technology, reached the market or are in the
clinical phase of development (Listerine Pocket-
Paks, BioEnvelop, MonoSol Rx, BioFilm, Snoreeze,
Triaminic, RapidFilm [4], Ora-Film [5]).
OTFs have some advantages over ODTs. The
mechanical properties of the films are better than
those of ODTs due to their flexibility. OTFs have
higher surface to contact with the saliva and the dis-
solution can be faster. However oral thin films
often contain ingredients insoluble in water such as
microcrystalline cellulose to promote disintegra-
tion. Insoluble particles can be inconvenient for
patients and furthermore they have to be swal-
lowed.
Electrostatic spinning (Electrospinning, ES) is a
dynamically developing technology which has
been primarily applied in the textile/filtration
industry. The ES technology is based on the impact
of high electric field on polymer solutions generat-
ing polymer fibers in the submicron scale when the
electric forces overcome the surface tension. The
setup consist of a solution feeder and a high voltage
power supply which is connected to a spinneret and
a collector electrode. Usually the latter one is
grounded. The solution on the spinneret electrode
forms a droplet which can interact with electro-
static field. The droplet gains a cone-shape and thin
jet can emerge from the tip of the cone. Fibers are
drawn by electrostatic forces between the two elec-
trodes and the solvent evaporates, resulting in solid
nanofibers. The prepared non-woven web is remov-
able from the grounded collector as a sheet. There
are numerous promising research activities in vari-
ous relevant areas such as composites [6–11], ster-
ile filtration [12], wound dressing [13, 14], wound
healing [15], tissue engineering [16–19] and semi-
conductors [20]. This technique is relatively new in
the field of medical industry and ES is quite slightly
known in pharmaceutical technology, where most
of the relevant papers deal with sustained drug
release [21]. Immediate release from nonwoven
system of electrospun nanofibers (called mat or
web generally) has been published only in some
cases [22–25]. Consequently the reviews dealing
with fast dissolving oral dosage forms such as
OTFs, and ODTs missed to mention this technol-
ogy [3, 5, 26–28].
Formation of non-woven tissues of the nanofibers,
owing to their huge surface area, is a promising way
to develop oral fast-dissolving dosage forms and the
electrostatic spinning can be a capable technology
for manufacturing such formulations. The wide ver-
satility of the polymers available for this purpose
supports this idea. Papers dealing with immediate
release from electrospun mat applied organic sol-
vents during their electrospinning process [22–25].
The aim of this work was to investigate applicabil-
ity of organic solvent free electrostatic spinning
method to produce orally dissolving formulation
(ODW = Orally Dissolving Web) using a water sol-
uble model drug. Donepezil HCl, administered
against Alzheimer’s disease, was chosen as an
example because its ODT formulation is available
on the market (Aricept ODT, Eisai) and its OTF
formulation, developed using Rapidfilm technol-
ogy (LabTec), is under clinical testing.
2. Materials and methods
2.1. Materials
The model drug Donepezil HCl (Figure 1) was
kindly provided by Richter Plc (Budapest, Hun-
gary).
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Figure 1. Chemical structure of Donepezil HCl
Poly(vinyl-alcohol) (Mw = 31 000 Da), purchased
from Fluka (Buchs, Switzerland), PVA-PEG graft
copolymer of Kollicoat IR type (BASF, Lud-
wigshafen, Germany) and Pharmacoat 606 HPMC
hydroxypropylmethylcellulose (Shin-Etsu, Tokyo,
Japan), were used as polymer matrices.
2.2. Preparation of solutions
The polymer was added into 10 ml purified water
and stirred by ARE magnetic stirrer (VELP Scien-
tifica, Usmate, Italy) at 600 rpm and 50°C till the
complete dissolution. The API was dissolved in the
solution of the polymer (magnetic stirrer, 600 rpm,
25°C). The compositions of PVA based solutions
are presented in Table 1.
2.3. Electrostatic spinning process
The electrostatic spinner used for the experiments
was equipped with NT-35 High Voltage DC Sup-
ply (MA2000, Nagykanizsa, Hungary). The uti-
lized electrical potential on the spinneret electrode
was between 10–35 kV which was adjusted during
the experiments. A grounded aluminium plate cov-
ered with aluminium foil or thin PVA film was
used as collector. The distance of the spinneret and
the collector was 15 cm and the experiments were
performed at room temperature (25°C). Polymer
solutions were dosed by SEP-10S Plus syringe
pump (Aitecs, Vilnius, Lithuania). Electrospinning
process was repeated 2 times to investigate the
repeatability in the case of the drug containing
compositions. Samples (equivalent to 10 mg
Donepezil HCl) were cut from 3 different places of
the collected web and were assayed by dissolution
test. The weights of the cut PVA:Do 5:1 and
PVA:Do 2:1 samples were ~60 and ~30 mg,
respectively.
2.4. Rheological measurements
Viscosity of the solutions was determined by AR
2000 Rotational Rheometer (TA Instruments, New
Castle, USA) in a parallel plate configuration. The
upper moved portion was a 40 mm diameter stain-
less steel plate. The lower portion was a Peltier
plate covered by Teflon and the applied gap between
the plates was 0.5 mm. The temperature of the solu-
tions was adjusted to 25°C by the Peltier thermo-
element. The viscosities were measured at torques
increased logarithmically from 10 to 1000 μNm·Pa.
The viscosities shown in the Table 2 are the aver-
age of 10 measured values at different torques (no
significant changes were estimated as a function of
the torque).
2.5. Conductivity tests
Conductivity of the solutions was measured using a
Radelkis OK-102/1 conductivity meter (Radelkis,
Budapest, Hungary). The electrode was immersed
into the solution and the measurement was carried
out at 25°C. The results given in Table 2 represent
the average of 3 parallel measurements.
2.6. Scanning electron microscopy (SEM)
Morphology of the samples was investigated by a
JEOL 6380LVa (JEOL, Tokyo, Japan) type scan-
ning electron microscope. Each specimen was fixed
by conductive double sided carbon adhesive tape
and sputtered by gold (using JEOL 1200 instru-
ment) in order to avoid electrostatic charging.
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Table 1. Composition of PVA based solutions
Samples PVA
[g]
Water
[ml]
Do
[g]Number Referred as
1 PVA 10% 1.11 10 0
2 PVA 15% 1.76 10 0
3 PVA 20% 2.50 10 0
4 PVA:Do 5:1 2.50 10 0.50
5 PVA:Do 2:1 2.50 10 1.25
Table 2. Viscosity and conductivity of the solutions at 25°C
Sample Viscosity [Pa·s] (n=10) Standard deviation [Pa·s] Conductivity [mS/cm] (n=3) Standard deviation [mS/cm]
Water 0.00088 0.00026 0.023 0.002
PVA 10% 0.02590 0.00140 0.760 0.050
PVA 15% 0.10900 0.00800 0.940 0.040
PVA 20% 0.39500 0.01500 1.040 0.060
PVA:Do 5:1 0.40900 0.01100 3.700 0.110
PVA:Do 2:1 0.52100 0.01700 7.500 0.110
2.7. Film casting
Donepezil HCl containing PVA films (PVA:Do 5:1
and 2:1) were also prepared by casting method to
compare the dissolution rate of electrospun mats
and cast films. PVA was dissolved in purified water
with magnetic stirrer at 50°C and 600 rpm (ARE
Magnetic Stirrer, VELP Scientifica, Usmate, Italy).
After the complete dissolution of the polymer
Donepezil HCl was added into the solution at room
temperature (25°C). Then the solution of the poly-
mer and the drug was cast into square silicone
moulds (4×100×100 mm). After evaporation of the
water (room temperature, 3 days) the films were
removed and stored at room temperature. The
thicknesses of the prepared films were between 100
and 110 μm measured by Pro-Max electronic digi-
tal caliper (NSK, Tokyo, Japan). For dissolution
tests squared films were cut equivalent to 10 mg
Donepezil HCl.
2.8. In vitro drug dissolution measurement
The dissolution studies were performed by Erweka
DT6 dissolution tester (USP II apparatus, Erweka,
Heusenstamm, Germany). 3-3 samples were inves-
tigated from the two parallel electrospinning
process in the cases of PVA:Do 5:1 and PVA:Do
2:1. Electropun samples to 10 mg Donepezil HCl
were placed in the dissolution vessel containing
900 ml distilled water maintained at 37±0.5°C and
stirred at 50 rpm. Samples (5 ml) were collected
after 0.5, 1, 1.5, 2, 2.5, 5, 10, 15, 20 and 30 minutes
and were analyzed by Hewlett-Packard HP 8452A
UV-VIS spectrophotometer (Palo Alto,USA) using
diode array detector at 272 nm. Concentration of
Donepezil HCl in the collected samples could be
easily calculated with the help of the calibration
curve of pure Donepezil HCl in water (since PVA
has no detectable absorbance at this wavelength).
For comparison 3 parallel samples of cast films
(10 mg Donepezil HCl) with same composition as
electrospun samples and six commercial Aricept
peroral tablets (10 mg Donepezil HCl) were
assayed. The collected liquid samples were filtrated
through 0,22 μm membrane in the case of tablets.
2.9. Modeling oral dissolution 
5 ml purified water was poured in a Petri dish (d =
5 cm). Electrospun samples were placed onto the
surface of the water by a clip. The weight of the
samples was ~60 mg for electrospun PVA placebo,
while ~30 and ~60 mg for electrospun PVA:Do 2:1
and electrospun PVA:Do 5:1 respectively. Dissolu-
tion (disappearance) was investigated visually and
the time of disappearance was measured. Six paral-
lel assays were carried out on each composition
(electrospun PVA placebo, electrospun PVA:Do
5:1 and electrospun PVA:Do 2:1).
In vivo dissolution (disappearance) test was also
performed by electrospun PVA placebo. Electro-
spun samples (60 mg) were placed onto the tongue
of a volunteer and the time of disappearance of the
web was measured. Six parallel tests were per-
formed.
3. Results and discussion
3.1. Selection of the polymer
Different polymers were applied to prepare ade-
quate web for fast dissolution. The compared poly-
mers were as follows: PVA, HPMC, PVA-PEG
graft copolymer. The first characteristic of these
polymers to be taken into consideration was their
solubility and dissolution. For the purposes of pres-
ent application the polymer has to be soluble in the
water based medium of salvia and the dissolution
time has to be as short as possible. The polymers
applicable for pharmaceutical purposes are quite
limited due to the stringent regulations. Several
water soluble and insoluble polymers are applied
by filmcoating technology, which is a rapidly devel-
oping part of pharmaceutical industry. In the most
cases tablet coatings have to dissolve rapidly to
avoid any delay in the action of APIs. Thus poly-
mer components of fast dissolving filmcoatings are
good candidates to develop orally dissolving sys-
tems.
Donepezil HCl has appropriate water solubility
therefore the preferred solvent for electrospinning
was pure water. Sequences of polymer water solu-
tions of different concentrations were tested by the
electrospinning apparatus. It was found that the
selected type of cellulose derivate (see in the 2.1) is
not adaptable for preparing suitable web for oral
dissolution at any concentration in water. The
experiments performed by water solutions of PVA-
PEG graft copolymer were more successful but
separated non fibrous particles were found as a
result on the collector when the concentration was
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≤ 20 w/w%. (At higher concentration there was not
any utilizable material on the collector.) In the case
when separated particles are formed instead of
fibers the method is called electrospraying. With
this process fine particles are readily producible but
it is not the subject of this paper.
PVA solutions resulted promising fibrous web at
various concentrations therefore further investiga-
tions were performed using PVA-based systems.
3.2. Morphology of the electrospun
poly(vinyl-alcohol) webs
The morphology of the electrospun products as a
function of the concentration of the polymer solu-
tion was examined by SEM. Varying the concentra-
tion of PVA solution in course of the electrospin-
ning process beaded-fibers were gained at 10 w/w%
while at higher concentrations (15, 20%) fibers of
different thickness were formed owing to the
increased viscosity and higher entanglement of the
polymer chains. The concentration of 20 w/w%
was found to be optimal for getting stabile structure
of discrete fibres (Figure 2). 
The structure shown in Figure 2c was expected to
be important both from the diffusion and dissolu-
tion point of view. The drug diffusion in solid poly-
mer matrix and consequently its crystal-growing
process can be hindered, keeping them in nanocrys-
tal range, when the discrete fibers are obtained. (No
three-dimensional diffusion can occur.) Concern-
ing the dissolution it was expected that not only
faster dissolution rate of nanocrystals, enclosed in
the fibers, can be achieved (owing to the higher sur-
face area), but the total solubility can be higher as
well comparing to large particles. The chance for it
is based on the enhanced angle of curvature of the
fine fibers resulting in higher surface energy, which
in turn modifies the equilibrium solubility. (The
particle size effect on the solubility is significant in
the nanorange, while above several microns it is
negligible.) Enhanced solubility influences the
bioavailability of the drug substantially.
Diameter of the fibers and the beads was deter-
mined by the aid of the software provided by the
SEM analyzer. Particle size of the beads was
around 1 μm (see in Figure 2a) and the diameter of
the fibers was in the range of hundred nanometers.
The mean fiber diameter of the electrospun PVA
20 w/w% solution was between 100–130 nm
according to Figure 3. These very thin fibers have
huge enough surface area to increase the dissolu-
tion rate significantly.
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Figure 2. Scanning electron microscopic (SEM) images of
PVA water solutions (magnification: 10 000×):
a) PVA 10%, b) PVA 15%, c) PVA 20%
3.3. Morphology of the drug-containing
electrospun fibers
Addition of Donepezil HCl (PVA:Do, 5:1) into the
solution of PVA does not have significant effect on
the technology and on the diameter. The mean
diameter was between 100–150 nm (Figure 4).
When the polymer drug ratio was increased up to
33 w/w% (PVA:Do, 2:1) the diameter of the elec-
trospun fibers increased slightly, but it still not
exceeding the 300 nm (Figure 5).
3.4. Rheology and conductivity of solutions
The entanglement of PVA chains depends on the
PVA concentration of the aqueous solutions, which
consequently determines its rheological behaviour
during the electrospinning process. Addition 10 and
20 w/w% of PVA into water leads to 30 and
450 times higher viscosity respectively than the
viscosity of pure water (Table 2). At low polymer
concentration (≤10 w/w%) there is not enough
entanglement between the polymer chains for
increasing the viscosity and thus maintaining a uni-
form fiber stream that is the reason why beads or
beaded fibers are formed during the electrostatic
spinning [29]. Increased entanglement of PVA
chains and consequently increased viscosity in the
case of ~20 w/w% concentration results in stable
fibrous morphology.
The viscosity of PVA 20% solution was not affected
significantly by addition 4 w/w% Donepezil HCl
and diameters of electrospun fibers did not changed
noticeably. (Donepezil HCl of 4w/w% in the solu-
tion means (after the evaporation of water)
~16.7 w/w% in the solid electrospun product.)
Increasing the Donepezil HCl concentration up to
10 w/w% in the PVA-water solution (33 w/w% in
the solid product) leads to slightly increased viscos-
ity and somewhat enlarged fiber thickness. It is con-
cluded that the presence of the small Donepezil HCl
molecules has a minor effect on the viscosity in this
range of concentration.
However, the effect Donepezil HCl from the point
of view of the conductivity is considerable. Addi-
tion of Donepezil HCl into the PVA solution
increased the conductivity significantly as given in
Table 2. Baumgarten [30] found that increasing of
conductivity of the acrylic polymer solution
decreased the diameter of fibers due to the stronger
interaction between the solution and the electric
field. However, according to our finding, the
increased conductivity raised the viscosity of the
solution slightly and the viscosity (and increased
dry solid content) influenced the diameter of fibers
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Figure 5. Scanning electron microscopic image of electro-
spun PVA:DO 2:1 (magnification 20 000×)
Figure 4. Scanning electron microscopic image of electro-
spun PVA:Do 5:1 (magnification 20 000×)
Figure 3. Scanning electron microscopic image of electro-
spun PVA 20% water solution (magnification
30 000×)
more significantly than the effect of increased con-
ductivity.
3.5. Drug dissolution investigation 
The prepared drug loaded samples of described
morphology were considered promising for oral
dissolution because of good water solubility of the
applied fiber-forming polymer and the huge surface
of the formed fibers. PVAs of high molecular weight
were applied earlier in electrospinning for control-
ling and sustaining drug release through gel forma-
tion [31]. However, in this work the instant dissolu-
tion was the aim therefore PVA of low molecular
weight (31 000 Da) was selected having moderate
tendency for gel formation.
Figures 6 and 7 show the drug release profiles of
electrospun webs, cast films with the same compo-
sition and commercial tablets. (Data of the samples
from the two parallel electrospinning processes are
represented in one plot because there were no sig-
nificant differences between the samples collected
from these processes.)
The considerable difference between the rates of dis-
solution of different samples is well recognizable.
Dissolution of cast films was dependent of their
drug content. Drug release of PVA:Do 2:1 cast
films was significantly faster than that of PVA:Do
5:1. Probably Donepezil HCl as a small molecule
with good water solubility can get easily into the
solution phase, while PVA as a macromolecule dis-
solves slower if its long polymer chains are less
plasticized by the drug molecules allowing larger
extent of entanglement, inter- and intramolecular
H-bonds. It means that PVA has retardant effect
excepting the case when formation of extremely
huge surface area decreases the value of bulk of
entangled structure.
The electrospun webs, independently of their drug
concentration, were dissolved immediately after
immersion in dissolution media owing to the
formed huge surface area. The correlation of sur-
face area and dissolution rate, corresponding to the
Noyes and Whitney equation [32], is described by
Equation (1):
(1)
where dC/dt is the dissolution rate, D, the diffusion
coefficient, A, the surface area exposed to the disso-
lution media, h, the diffusion layer thickness, V, the
volume of the dissolution media, Cs, the saturation
solubility of the drug and Ct, the drug concentration
at time t.
The equation shows that the dissolution rate is
directly proportional to the surface area exposed to
the dissolution media.
Modeling of oral dissolution of electrospun webs
showed similar results as the standard USP II disso-
lution method. The disappearance time of the sam-
ples was 13±6 s, 11±4 s, 6±3 s for electrospun
PVA placebo, electrospun PVA:Do 5:1 and electro-
spun PVA:Do 2:1, respectively. Time of disappear-
ance increased slightly in the function of decreas-
ing drug content but all electrospun samples
fulfilled the requirement of fast dissolution (<30 s). 
In vivo assays were carried out using electrospun
PVA placebo which had the longest dissolution
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=
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Figure 6. In vitro dissolution of Donepezil HCl (dose
10 mg, 900 ml distilled water, 50 rpm, 37°C):
(A) Electrospun web of PVA-Do ratio 5:1
(n = 6), (B) Commercial Aricept tablet (dose
10 mg, n = 6), (C) Cast film of PVA-Do ratio
5:1 (n = 3)
Figure 7. In vitro dissolution of Donepezil HCl (dose
10 mg, 900 ml distilled water, 50 rpm, 37°C):
(A) Electrospun web of PVA-Do ratio 2:1
(n = 6), (B) Cast film of PVA-Do ratio 2:1
(n = 3), (C) Commercial Aricept tablet (dose
10 mg, n = 6)
time of electrospun samples. The average disap-
pearance time of the webs on the volunteers tongue
was 9±6 s. The obtained results confirmed the pos-
sible applicability of electrospun PVA webs for
oral dissolving dosage forms.
Electrospinning provides a very effective tool to
increase the surface area and thus speed up the dis-
solution rate. Future perspectives of the way of
administration of electrospun webs are considered
quite wide. Owing to the variability of electrospin-
ning process the physical properties of the electro-
spun web can be tailored to the requirements of
certain applications. If it has proper physical behav-
iors (tensile strength, rigidity, … etc.) it can be used
simply by cut out the area of adequate dosage from
non-woven fabric produced. In all cases the uni-
form thickness of the web has to be ensured.
Another possibility is application of a flat biocom-
patible solid carrier which can be the collector dur-
ing the electrospinning. It can be conductive or
non-conductive material as well. For demonstration
PVA film (Mw = 31 000 Da) plasticized with poly-
ethyleneglycol (PEG, Mw = 4000 Da) was used as
collector during the electrospinning and the
obtained double-layer structure was easy to handle
and could be administered readily (Figure 8). 
For industrial application of orally dissolving webs
larger scale production has to be available. Scaling-
up of electrospinning process is in the focus of sev-
eral researches. Nowadays there are some promis-
ing systems available, such as Nanospider technol-
ogy (Elmarco, Czech Republic). The 10 kg/day
PVA web production capacity of this method
means more than 100 000 units/day (if the dosage
is 10 mg and one drug unit is 100 mg), which can
fulfill the requirements of the pharmaceutical
industry.
4. Conclusions
Orally dissolving drug delivery systems have
increasing attention in industrial and academic field
too. Donepezil HCl, administered generally against
Alzheimer’s disease, was introduced into PVA
solution and fabricated to nanofibers by electro-
spinning. Owing to the formed huge surface area
the drug release was found immediate from the
fibers. The developed method needs very low energy
input and works at ambient temperature. This tech-
nology might be suitable for industrial scaling up
owing to the recent rapid development of industrial
electrospinning technology mainly in the textile
and filtration industry [33]. The prepared PVA
based nanofibrous orally dissolving web (ODW)
formulation is a promising way for producing
acceptable and effective dosage forms for children,
older people, patients with dysphagia and so on.
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